RGNX - REGENXBIO Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.56B
Enterprise Value 31.26B
Trailing P/E N/A
Forward P/E 1-14.55
PEG Ratio (5 yr expected) 1-6.70
Price/Sales (ttm)17.89
Price/Book (mrq)3.19
Enterprise Value/Revenue 314.50
Enterprise Value/EBITDA 6-27.99

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -41.99%
Operating Margin (ttm)-57.28%

Management Effectiveness

Return on Assets (ttm)-7.45%
Return on Equity (ttm)-9.29%

Income Statement

Revenue (ttm)87M
Revenue Per Share (ttm)2.51
Quarterly Revenue Growth (yoy)-99.30%
Gross Profit (ttm)124.99M
EBITDA -45.07M
Net Income Avi to Common (ttm)-36.53M
Diluted EPS (ttm)-1.05
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)285.22M
Total Cash Per Share (mrq)7.78
Total Debt (mrq)7.88M
Total Debt/Equity (mrq)1.62
Current Ratio (mrq)14.21
Book Value Per Share (mrq)13.30

Cash Flow Statement

Operating Cash Flow (ttm)17.22M
Levered Free Cash Flow (ttm)-2.39M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.84
52-Week Change 3-9.70%
S&P500 52-Week Change 34.71%
52 Week High 385.10
52 Week Low 338.56
50-Day Moving Average 350.61
200-Day Moving Average 351.75

Share Statistics

Avg Vol (3 month) 3589.41k
Avg Vol (10 day) 3498.18k
Shares Outstanding 536.64M
Float 28.66M
% Held by Insiders 115.70%
% Held by Institutions 183.65%
Shares Short (Apr 30, 2019) 43.25M
Short Ratio (Apr 30, 2019) 46.32
Short % of Float (Apr 30, 2019) 411.50%
Short % of Shares Outstanding (Apr 30, 2019) 48.87%
Shares Short (prior month Mar 29, 2019) 43.52M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A